33
Participants
Start Date
May 26, 2022
Primary Completion Date
December 12, 2022
Study Completion Date
December 12, 2022
Ketamine
Ketamine IV administration
Hassman Research Institute, Marlton
Alkermes, Inc.
INDUSTRY
Anavex Life Sciences Corp.
INDUSTRY
Astellas Pharma Inc
INDUSTRY
H. Lundbeck A/S
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY
Novartis
INDUSTRY
Sage Therapeutics
INDUSTRY
Takeda
INDUSTRY
Apex Innovative Sciences
UNKNOWN
COGNISION
UNKNOWN
ERP Biomarker Qualification Consortium
INDUSTRY